Top 20 high-impact clinical research articles of 2024 in Gastroenterology:Episode 9

Clinical Gastroenterology and Hepatology ​​Coconut Water Induces Clinical Remission in Mild to Moderate Ulcerative Colitis: Double-blind Placebo-controlled TrialThis research investigated whether coconut water (CW) could serve as an effective adjunct therapy for individuals with mild to moderate ulcerative colitis (UC), a condition it may help by manipulating the gut microbiome and reducing inflammation. In a double-blind, placebo-controlled trial, patients were randomly assigned to receive either coconut water or a placebo, in addition to their standard medical treatment for eight weeks. The findings demonstrated that the group receiving coconut water showed significantly higher rates of clinical remission and improved clinical response compared to the placebo group. Ultimately, the study concluded that CW is a more effective method than a placebo for inducing clinical remission in patients dealing with mild to moderate UC.